AVEO Oncology (AVEO) Reports Q3 EPS of $0.10, Offers Guidance

November 12, 2019 7:29 AM

AVEO Oncology (NASDAQ: AVEO) reported Q3 EPS of $0.10, versus ($0.18) reported last year. Revenue for the quarter came in ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found